Cambridge, United Kingdom

Mark Patrick Healy


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark Patrick Healy: Innovator in Pharmaceutical Compounds

Introduction

Mark Patrick Healy is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 3 patents to his name, Healy's work has the potential to impact various therapeutic areas.

Latest Patents

Healy's latest patents include innovative compounds such as pyrazine compounds, which are characterized by a specific formula involving phenyl substitutions and various nitrogen configurations. These compounds are designed to have pharmaceutically acceptable derivatives, showcasing their potential utility in medicine. Another significant patent focuses on triazine compounds aimed at treating central nervous system (CNS) disorders, further emphasizing his commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Healy has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Wellcome Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development efforts.

Collaborations

Healy has collaborated with esteemed colleagues such as Brian Cox and Malcolm Stuart Nobbs. These partnerships have likely enriched his work and fostered an environment of innovation and creativity.

Conclusion

Mark Patrick Healy's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant figure in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…